Stock Analysis

Weak Statutory Earnings May Not Tell The Whole Story For Lalique Group (VTX:LLQ)

SWX:LLQ
Source: Shutterstock

Lalique Group SA's (VTX:LLQ) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern.

See our latest analysis for Lalique Group

earnings-and-revenue-history
SWX:LLQ Earnings and Revenue History April 26th 2024

To understand the value of a company's earnings growth, it is imperative to consider any dilution of shareholders' interests. As it happens, Lalique Group issued 7.1% more new shares over the last year. As a result, its net income is now split between a greater number of shares. To celebrate net income while ignoring dilution is like rejoicing because you have a single slice of a larger pizza, but ignoring the fact that the pizza is now cut into many more slices. Check out Lalique Group's historical EPS growth by clicking on this link.

How Is Dilution Impacting Lalique Group's Earnings Per Share (EPS)?

Three years ago, Lalique Group lost money. And even focusing only on the last twelve months, we see profit is down 74%. Like a sack of potatoes thrown from a delivery truck, EPS fell harder, down 75% in the same period. So you can see that the dilution has had a bit of an impact on shareholders.

In the long term, if Lalique Group's earnings per share can increase, then the share price should too. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For the ordinary retail shareholder, EPS is a great measure to check your hypothetical "share" of the company's profit.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

How Do Unusual Items Influence Profit?

Alongside that dilution, it's also important to note that Lalique Group's profit was boosted by unusual items worth €1.8m in the last twelve months. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. Lalique Group had a rather significant contribution from unusual items relative to its profit to December 2023. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.

Our Take On Lalique Group's Profit Performance

To sum it all up, Lalique Group got a nice boost to profit from unusual items; without that, its statutory results would have looked worse. On top of that, the dilution means that its earnings per share performance is worse than its profit performance. For the reasons mentioned above, we think that a perfunctory glance at Lalique Group's statutory profits might make it look better than it really is on an underlying level. If you'd like to know more about Lalique Group as a business, it's important to be aware of any risks it's facing. Every company has risks, and we've spotted 4 warning signs for Lalique Group you should know about.

In this article we've looked at a number of factors that can impair the utility of profit numbers, and we've come away cautious. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

Valuation is complex, but we're helping make it simple.

Find out whether Lalique Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.